Trends & Forecasts

Oncology medication prices can vary significantly between countries – but by how much and why?

2015 has been a difficult year for Indian pharma companies – and ASSOCHAM is calling for the country to get its “house in order”.

The AMA calls for a ban on direct-to-consumer drug advertising in the US. But is such prohibition realistic?

Pfizer and Allergan are to combine to form the world’s biggest pharma behemoth – for tax?

Considering Ebola's impact, how can we incentivize development in other important health areas?

Is the reverse merger between Pfizer and Allergan the most recent chapter in a troubling trend?

How do your customers, your competitors, the press or even the public perceive your organization?

Sitting Down With... Raman Singh, President, Mundipharma Asia Pacific, Latin America, Middle East and Africa.

Polymorphic conversions are an ongoing problem in the pharmaceutical industry.

In this white paper, we report the use of the thermal stability data obtained from DSC to screen conditions for viral inactivation of an antibody1.